Literature DB >> 11291998

Orphanin FQ/nociceptin attenuates motor stimulation and changes in nucleus accumbens extracellular dopamine induced by cocaine in rats.

K Lutfy1, T Do, N T Maidment.   

Abstract

RATIONALE: Orphanin FQ (OFQ; also known as nociceptin), the endogenous ligand of the opioid receptor-like receptor, injected intracerebroventricularly (i.c.v.) decreases basal motor activity and basal extracellular levels of dopamine (DA) in the nucleus accumbens (Nuc Acc) in rats.
OBJECTIVE: The present study was designed to determine if OFQ similarly attenuates cocaine-induced motor stimulation and to determine if this effect is dependent on attenuation of the increase in extracellular DA.
METHODS: After a 1-h adaptation period, rats were injected with either artificial cerebrospinal fluid or OFQ (3-30 nmol, i.c.v.) 5 min prior to cocaine (10 mg/kg, i.p.) or apomorphine (3 mg/kg, i.p.) administration and the total distance traveled was measured for a further 1 h. In a separate experiment, changes in extracellular DA were monitored by microdialysis following cocaine and OFQ treatment in anesthetized rats.
RESULTS: OFQ dose-dependently attenuated both basal and cocaine-induced motor stimulation. OFQ (30 nmol, i.c.v.) also attenuated both the basal and the cocaine-induced increase in extracellular DA in the Nuc Acc. OFQ, at the highest dose, also decreased the motor stimulation induced by apomorphine.
CONCLUSIONS: Our results suggest that the modulatory effect of OFQ on locomotor activity is not solely due to its inhibitory action on extracellular DA in the Nuc Acc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11291998      PMCID: PMC2288655          DOI: 10.1007/s002130000609

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  25 in total

1.  Nociceptin induced inhibition of K+ evoked glutamate release from rat cerebrocortical slices.

Authors:  B Nicol; D G Lambert; D J Rowbotham; D Smart; A T McKnight
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

2.  The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion.

Authors:  D P Devine; R K Reinscheid; F J Monsma; O Civelli; H Akil
Journal:  Brain Res       Date:  1996-07-15       Impact factor: 3.252

3.  Intracerebroventricular orphanin FQ/nociceptin suppresses dopamine release in the nucleus accumbens of anaesthetized rats.

Authors:  N P Murphy; H T Ly; N T Maidment
Journal:  Neuroscience       Date:  1996-11       Impact factor: 3.590

Review 4.  The neural basis of drug craving: an incentive-sensitization theory of addiction.

Authors:  T E Robinson; K C Berridge
Journal:  Brain Res Brain Res Rev       Date:  1993 Sep-Dec

5.  Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type.

Authors:  J R Bunzow; C Saez; M Mortrud; C Bouvier; J T Williams; M Low; D K Grandy
Journal:  FEBS Lett       Date:  1994-06-27       Impact factor: 4.124

6.  Injections of nociceptin into nucleus accumbens shell or ventromedial hypothalamic nucleus increase food intake.

Authors:  T R Stratford; M R Holahan; A E Kelley
Journal:  Neuroreport       Date:  1997-01-20       Impact factor: 1.837

7.  Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ.

Authors:  D P Devine; L Taylor; R K Reinscheid; F J Monsma; O Civelli; H Akil
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

8.  Distribution of nociceptin/orphanin FQ receptor transcript in human central nervous system and immune cells.

Authors:  J Peluso; K S LaForge; H W Matthes; M J Kreek; B L Kieffer; C Gavériaux-Ruff
Journal:  J Neuroimmunol       Date:  1998-01       Impact factor: 3.478

9.  Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor.

Authors:  J C Meunier; C Mollereau; L Toll; C Suaudeau; C Moisand; P Alvinerie; J L Butour; J C Guillemot; P Ferrara; B Monsarrat
Journal:  Nature       Date:  1995-10-12       Impact factor: 49.962

10.  Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor.

Authors:  R K Reinscheid; H P Nothacker; A Bourson; A Ardati; R A Henningsen; J R Bunzow; D K Grandy; H Langen; F J Monsma; O Civelli
Journal:  Science       Date:  1995-11-03       Impact factor: 47.728

View more
  41 in total

1.  Inhibition of striatal and retinal dopamine release via nociceptin/orphanin FQ receptors.

Authors:  K Flau; A Redmer; S Liedtke; M Kathmann; E Schlicker
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

2.  Buprenorphine requires concomitant activation of NOP and MOP receptors to reduce cocaine consumption.

Authors:  Marsida Kallupi; Qianwei Shen; Giordano de Guglielmo; Dennis Yasuda; V Blair Journigan; Nurulain T Zaveri; Roberto Ciccocioppo
Journal:  Addict Biol       Date:  2017-06-21       Impact factor: 4.280

3.  Regarding "Buprenorphine reduces alcohol drinking through activation of the nociceptin/orphanin FQ-NOP receptor system".

Authors:  David A Gorelick
Journal:  Biol Psychiatry       Date:  2007-05-25       Impact factor: 13.382

4.  Orphanin FQ/nociceptin not only blocks but also reverses behavioral adaptive changes induced by repeated cocaine in mice.

Authors:  David Bebawy; Paul Marquez; Seroje Samboul; Drupad Parikh; Abdul Hamid; Kabirullah Lutfy
Journal:  Biol Psychiatry       Date:  2010-03-31       Impact factor: 13.382

5.  Nociceptin receptor activation does not alter acquisition, expression, extinction and reinstatement of conditioned cocaine preference in mice.

Authors:  G C Sartor; S K Powell; H J Wiedner; C Wahlestedt; S P Brothers
Journal:  Brain Res       Date:  2015-12-03       Impact factor: 3.252

6.  A Novel and Selective Nociceptin Receptor (NOP) Agonist (1-(1-((cis)-4-isopropylcyclohexyl)piperidin-4-yl)-1H-indol-2-yl)methanol (AT-312) Decreases Acquisition of Ethanol-Induced Conditioned Place Preference in Mice.

Authors:  Nurulain T Zaveri; Paul V Marquez; Michael E Meyer; Willma E Polgar; Abdul Hamid; Kabirullah Lutfy
Journal:  Alcohol Clin Exp Res       Date:  2018-01-19       Impact factor: 3.455

7.  Nociceptin Receptors Upregulated in Cocaine Use Disorder: A Positron Emission Tomography Imaging Study Using [11C]NOP-1A.

Authors:  Rajesh Narendran; Savannah Tollefson; Michael L Himes; Jennifer Paris; Brian Lopresti; Roberto Ciccocioppo; N Scott Mason
Journal:  Am J Psychiatry       Date:  2019-05-06       Impact factor: 18.112

8.  Chronic cocaine produces decreases in N/OFQ peptide levels in select rat brain regions.

Authors:  Patrizia Romualdi; Manuela Di Benedetto; Claudio D'Addario; Stephanie L Collins; Dean Wade; Sanzio Candeletti; Sari Izenwasser
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

9.  Buprenorphine: a unique drug with complex pharmacology.

Authors:  Kabirullah Lutfy; Alan Cowan
Journal:  Curr Neuropharmacol       Date:  2004-10       Impact factor: 7.363

Review 10.  Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems.

Authors:  Lawrence Toll; Michael R Bruchas; Girolamo Calo'; Brian M Cox; Nurulain T Zaveri
Journal:  Pharmacol Rev       Date:  2016-03-08       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.